Tempest Therapeutics, Inc. (TPST): Insider Trading, Congress Trades & Research | Tormere

TPST

$0.47-0.72%visit website

Tempest Therapeutics, Inc.

Market Cap

$7M

Live price × Finnhub shares (2026-10-17)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

-1.45

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

—

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Research & development	570	539	114	1,819	3,042
Operating income	(3,597)	(4,077)	(27,719)	(5,250)	(40,643)
Interest expense	0.00	0.00	0.00	0.00	0.00
Income tax	0.00	0.00	0.00	0.00	0.00
Net income	(3,511)	(4,021)	(27,696)	(5,244)	(40,472)
EPS (basic) ($)	(0.79)		(2.53)	(0.34)	—
EPS (diluted) ($)	(0.79)		(2.53)	(0.34)	—
Weighted avg. shares (basic)	4,440		10,932	15,224
Weighted avg. shares (diluted)	4,440		10,932	15,224

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 13, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 57 more quarters, back to Jun 2011, with Tormere Pro.

Signals

Insider Velocity

no recent activity

purchases / sales, 90d

Market & Alt Data

News

15

recent articles

Analyst Consensus

Strong Buy

7 analysts

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-03-24	2026-03-25	Angel Matthew	Director & CEO and President	Purchase	231.5K	$2.16	$500K	231.5K	View

Recent News

Tempest Therapeutics, Inc. Initial Statement of Beneficial Ownership

Stock Titan · 2026-11-03

Tempest Therapeutics, Inc. SEC Filing (Nov 2, 2026)

Stock Titan · 2026-11-02

Tempest Therapeutics CFO Constance Ames Resigns; Co. Names Stephanie Horn-Warnock CFO, Treasurer, And Corporate Secretary, Effective Immediately.

Benzinga · 2026-10-30

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga · 2026-10-23

12 Health Care Stocks Moving In Wednesday's After-Market Session

Benzinga · 2026-10-21

Tempest Appoints John W. Frederick to Board of Directors, Strengthening Financial and Capital Markets Expertise

Yahoo · 2026-10-14

12 Health Care Stocks Moving In Monday's After-Market Session

Benzinga · 2026-10-12

Tempest Appoints Global Finance Leader Nancy Freda-Smith to Board of Directors

Yahoo Finance · 2026-09-23

Tempest Therapeutics Shares Surge 66.53% After Hours on CAR-T Deal - Tempest Therapeutics (NASDAQ:TPST)

Benzinga · 2026-09-16

TPST Stock Jumps As Tempest Therapeutics Expands CAR-T Pipeline

Timothy Sykes · 2026-09-16

Tempest Secures Exclusive Option to License Clinical-Stage CD7-Targeted Lentiviral In Vivo CAR-T Platform

Yahoo Finance · 2026-09-15

Tempest Therapeutics Announces Up to $7.5 Million Private Placement

Yahoo Finance · 2026-09-11

Tempest to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Yahoo Finance · 2026-09-08

Tempest Reports Second Quarter 2026 Financial Results and Provides Business Update

Yahoo Finance · 2026-08-13

Tempest Announces Development Collaboration with Senlang Biotechnology for TPST-4003, a CD7-Targeted Next-Generation In Vivo CAR-T

Yahoo Finance · 2026-07-21

Informational purposes only, not investment advice.